Design Therapeutics Sets IPO Offering Range
socalTECH
MARCH 23, 2021
Carlsbad-based Design Therapeutics, a company developing treatments for serious degenerative disorders, has set an expected IPO offering range of between $18.00 The company has applied to list on the Nasdaq Global Market as DSGN. The company is venture backed by SR One, Quan Capital, Cormorant Asset Management, and WestRiver Group.
Let's personalize your content